Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival

Table 1

Clinical characteristics of SOC patients.

Variables	Cases ()	DYRK3 expression level		value
		Low ()	High ()
Age (years)				0.158
≤60 yrs	153	71	82
>60 yrs	101	56	45
Laterality				0.148
Unilateral	190	90	100
Bilateral	64	37	27
Lymph node status				0.010
Negative	156	88	68
Positive	98	39	59
FIGO stage				<0.001
Stage I-II	79	59	20
Stage III	126	41	85
Stage IV	49	27	22
Chemotherapy				0.257
Yes	137	73	64
No	117	54	63

Abbreviations: LN: lymph node; SOC: serous ovarian cancer; DYRK3: dual-specificity tyrosine phosphorylation-regulated kinase 3; FIGO: International Federation of Gynecology and Obstetrics. Note: data was tested by two-sided chi-square test. indicates .